DIS vs MRK: Which Is the Better Buy?

Side-by-side comparison of The Walt Disney Company and Merck & Co., Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-06-20.
The Walt Disney Company Β· Communication Services
$103.89
+45.0% upside to fair value
Grade B High Quality
VS
Merck & Co., Inc. Β· Healthcare
$113.87
-12.1% upside to fair value
Grade D High Quality
QuantHub Verdict
DIS has more upside to fair value (+45.0%). DIS trades at a lower forward P/E (16.6x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric DIS MRK
Current Price $103.89 $113.87
Fair Value Estimate $150.64 $100.14
Upside to Fair Value +45.0% -12.1%
Market Cap $180.4B $281.2B
Forward P/E 16.6x 32.0x
EV / EBITDA 11.4x 17.3x
Price / Sales 1.9x 4.3x
Price / FCF 25.4x 19.9x
Revenue Growth YoY +6.5% +4.3%
Gross Margin 37.2% 75.9%
Operating Margin 15.5% 27.6%
Return on Equity 10.3% 17.9%
Dividend Yield 0% 0%
FCF Yield 3.94% 5.02%
Analyst Consensus Strong Buy Hold
Investment Thesis
DIS β€” The Walt Disney Company
The Walt Disney Company operates as a diversified entertainment conglomerate with strong positions in media networks, parks and experiences, and sports. The company benefits from a durable competitive moat driven by its iconic brand, extensive content library, and integrated ecosystem spanning streaming, theatrical, and physical experiences. Despite a 31.4% decline in earnings in the most recent …
MRK β€” Merck & Co., Inc.
Merck & Co., Inc. is a leading global healthcare company specializing in pharmaceuticals, vaccines, and animal health products. Its business quality is high, supported by a durable competitive moat anchored in the dominant global position of Keytruda in PD-1/PD-L1 oncology, a strong vaccines portfolio including Gardasil, and scale in R&D and manufacturing. The company benefits from a seasoned lea…
Accumulation Zones
Metric DIS MRK
Zone Low $112.98 $75.11
Zone High $128.04 $85.12
In Buy Zone? Yes No
← DIS Research    MRK Research β†’    All Research